Clinical Trials List
2020-10-26 - 2029-12-31
Phase III
Not yet recruiting6
Recruiting1
ICD-10C16.9
Malignant neoplasm of stomach, unspecified
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.9
Malignant neoplasm of stomach, unspecified
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
Co-Principal Investigator
- Yee Chao 無
- Yi-Ping Hung 無
- Shao-Jung Hsu 無
- Rheun-Chuan Lee 未分科
- 方文良 無
- Chung-Pin Li 無
- Yun-Cheng Hsieh 無
- Chien-An Liu 無
- San-Chi Chen 無
- 黃國宏 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Chi Chou 無
- Yung-Chia Kao 無
- Chun-Nan Yeh 無
- 蔡駿逸 無
- Wen-Chi Shen 無
- 黃文冠 無
- 劉耿豪 無
- 吳仁欽 無
- Hung-Chih Hsu 無
- Ming-Mo Hou 無
- 徐潤德 無
- 曾振輝 無
- Tsai-Sheng Yang 無
- Po-Jung Su 無
- Tai-Sen Yeh 無
- 李兆偉 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 劉奕廷 無
- 趙盈瑞 無
- Chia-Jui Yen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 陳德鴻 無
- 楊宏仁 無
- Chang-Fang Chiu 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
42 participants
-
Global
900 participants
